Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: Whither the evidence?

Neuroscience and Biobehavioral Reviews

Volumn 61, Issue , 2016, Pages 66-89

  Kuswanto, Carissa ^a   Chin, Rowena ^a   Sum, Min Yi ^a   Sengupta, Somnath ^a   Fagiolini, Andrea ^b   McIntyre, Roger S ^c   Vieta, Eduard ^d   Sim, Kang ^a  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar disorder; Neurocognitive impairments; Schizophrenia

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; AGE; ATTENTION; BIPOLAR DISORDER; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; GENDER; HOSPITALIZATION; HUMAN; INTELLIGENCE QUOTIENT; INTROSPECTION; MEDICAL HISTORY; MOOD DISORDER; MOTOR PERFORMANCE; MOTOR SPEED; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; REMISSION; REVIEW; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; VERBAL COMMUNICATION; VERBAL FLUENCY; WORKING MEMORY; COGNITION DISORDERS; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOSIS;

BIPOLAR DISORDER; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; EXECUTIVE FUNCTION; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84951003223     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.12.002     Document Type: Review

References (162)

1. Altshuler L.L., Ventura J., van Gorp W.G., Green M.F., Theberge D.C., Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol. Psychiatry 2004, 56(8):560-569.
2. Ancín I., Cabranes J.A., Santos J.L., Sánchez-Morla E., Barabash A. Executive deficits: a continuum schizophrenia - bipolar disorder or specific to schizophrenia?. J. Psychiatr. Res. 2013, 47(11):1564-1571.
3. Amann B., Gomar J.J., Ortiz-Gil J., McKenna P., Sans-Sansa B., Sarró S., Moro N., Madre M., Landin-Romero R., Vieta E., Goikolea J.M., Salvador R., Pomarol-Clotet E. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls. Psychol. Med. 2012, 42(10):2127-2135.
4. Anderson D., Ardekani B.A., Burdick K.E., Robinson D.G., John M., Malhotra A.K., Szeszko P.R. Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder. Bipolar Disord. 2013, 15(6):680-693.
5. Aleman A., Agrawal N., Morgan K.D., David A.S. Insight in psychosis and neuropsychological function: meta-analysis. Br. J. Psychiatry 2006, 189:204-212.
6. Arduini L., Kalyvoka A., Stratta P., Rinaldi O., Danulezzo E., Rossi A. Insight and neuropsychological function in patients with schizophrenia and bipolar disorder with psychotic features. Can. J. Psychiatry 2003, 48(5):338-341.
7. Arnone D., Cavanagh J., Gerber D., Lawrie S.M., Ebmeier K.P., McIntosh A.M. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br. J. Psychiatry 2009, 195(3):194-201.
8. Arts B., Jadden N., Krabbendam L., van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol. Med. 2008, 38(6):771-785.
9. Austin D., Jimison H., Hayes T., Mattek N., Kaye J., Pavel M. Measuring motor speed through typing: a surrogate for the finger tapping task. Behav. Res. Methods 2011, 43(4):903-909.
10. Baddeley A.D., Hitch G.J. Working memory. The Psychology of Learning and Memory 1974, 47-89. Academic, New York, USA. G.A. Dower (Ed.).
11. Balanzá-Martínez V., Tabarés-Seisdedos R., Selva-Vera G., Martínez-Arán A., Torrent C., Salazar-Fraile J., Leal-Cercós C., Vieta E., Gómez-Beneyto M. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother. Psychosom. 2005, 74(2):113-119.
12. Barch D.M., Bustillo J., Gaebel W., Gur R., Heckers S., Malaspina D., Owen M.J., Schultz S., Tandon R., Tsuang M., van Os J., Carpenter W. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophr. Res. 2013, 150(1):15-20.
13. Barnett J.H., Salmond C.H., Jones P.B., Sahakian B.J. Cognitive reserve in neuropsychiatry. Psychol. Med. 2006, 36:1053-1064.
14. Barrett S.Z., Mulholland C.C., Cooper S.J., Rushe T.M. Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia. Br. J. Psychiatry 2009, 195(1):67-72.
15. Bellivier F., Geoffroy P.A., Scott J., Schurhoff F., Leboyer M., Etain B. Biomarkers of bipolar disorder: specific or shared with schizophrenia?. Front. Biosci. (Elite Ed.) 2013, 5:845-863.
16. Berrios G.E., Beer D. The notion of a unitary psychosis: a conceptual history. Hist. Psychiatry 1994, 5(17 Pt 1):13-36.
17. Bonnín C.M., Torrent C., Goikolea J.M., Reinares M., Solé B., Valentí M., Sánchez-Moreno J., Hidalgo D., Tabarés-Seisdedos R., Martínez-Arán A., Vieta E. The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2014, 264(3):247-254.
18. Bora E., Yucel M., Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J. Affect. Disord. 2009, 113(2009):1-20.
19. Bora E., Yucel M., Fornito A., Berk M., Pantelis C. Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers. Acta Psychiatr. Scand. 2008, 118(3):172-187.
20. Bora E. Developmental trajectory of cognitive impairment in bipolar disorder: comparison with schizophrenia. Eur. Neuropsychopharmacol. 2015, 25(2):158-168.
21. Brandt C.L., Eichele T., Melle I., Sundet K., Server A., Agartz I., Hugdahl K., Jensen J., Andreassen O.A. Working memory networks and activation patterns in schizophrenia and bipolar disorder: comparison with healthy controls. Br. J. Psychiatry 2014, 204:290-298.
22. Brébion G., Bressan R.A., Ohlsen R.I., David A.S. A model of memory impairment in schizophrenia: cognitive and clinical factors associated with memory efficiency and memory errors. Schizophr. Res. 2013, 151(1-3):70-77.
23. Brissos S., Dias V.V., Carita A.I., Martinez-Aran A. Quality of life in bipolar I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res. 2008, 160(1):55-62.
24. Bromet E.J., Kotov R., Fochtmann L.J., Carlson G.A., Tanenberg-Karant M., Ruggero C., Chang S.W. Diagnostic shifts during the decade following first admission for psychosis. Am. J. Psychiatry 2011, 168(11):1186-1194.
25. Burdick K.E., Goldberg T.E., Cornblatt B.A., Keefe R.S., Gopin C.B., Braga R.J., Malhotra A. The MATRICS Consensus Cognitive Battery in patients with bipolar I disorder. Neuropsychopharmacology 2011, 36:1587-1592.
26. Burdick K.E., Russo M., Frangou S., Mahon K., Braga R.J., Shanahan M., Malhotra A.K. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol. Med. 2014, 44(14):3083-3096.
27. Burgess P.W., Veitch E., de lacy Costello A., Shallice T. The cognitive and neuroanatomical correlates of multi-tasking. Neuropsychologia 2000, 38(2000):848-863.
28. Caletti E., Paoli R.A., Fiorentini A., Cigliobianco M., Zugno E., Serati M., Orsenigo G., Grillo P., Zago S., Caldiroli A., Prunas C., Giusti F., Consonni D., Altamura A.C. Neuropsychology, social cognition and global functioning among bipolar, schizophrenic patients and healthy controls: preliminary data. Front. Hum. Neurosci. 2013, 7(661). 10.3389/fnhum.2013.00661.
29. Cannon M., Caspi A., Moffitt T.E., Harrington H., Taylor A., Murray R.M., Poulton R. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch. Gen. Psychiatry 2002, 59(5):449-456.
30. Chaves O.C., Lombardo L.E., Bearden C.E., Woolsey M.D., Martinez D.M., Barrett J.A., Miller A.L., Velligan D.I., Glahn D.C. Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study. Bipolar Disord. 2014, 13(1):118-123.
31. Cholet J., Sauvaget A., Vanelle J.M., Hommet C., Mondon K., Mamet J.P., Camus V. Using the Brief Assessment of Cognition in Schizophrenia (BACS) to assess cognitive impairment in older patients with schizophrenia and bipolar disorder. Bipolar Disord. 2014, 16(3):326-336.
32. Chepenik L.G., Wang F., Spencer L., Spann M., Kalmar J.H., Womer F., Kale E.E., Pittman B., Blumberg H.P. Structure-function associations in hippocampus in bipolar disorder. Biol. Psychol. 2012, 90(1):18-22.
33. Cirillo M.A., Seidman L.J. Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol. Rev. 2003, 13(2):43-77.
34. Cousins D.A., Butts K., Young A.H. The role of dopamine in bipolar disorder. Bipolar Disord. 2009, 11(8):787-806.
35. Craddock N., O'Donovan M.C., Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 2006, 32(1):9-16.
36. Craddock N., Owen M.J. The beginning of the end for the Kraepelinian dichotomy. Br. J. Psychiatry 2005, 186:364-366.
37. Damasio A.R. Towards a neurobiology of emotion and feeling: operational concepts and hypotheses. Neuroscientist 1995, 1(1):19-25.
38. Dantas C.R., Barros B.R., Fernandes P.T., Li L.M., Banzato C.E.M. Insight controlled for cognition in deficit and nondeficit schizophrenia. Schizophr. Res. 2011, 128(1-3):124-126.
39. De la Serna E., Andres-Perpina S., Puig O., Baeza I., Bombin I., Bartres-Faz D., Arango C., Gonzalez-Pinto A., Parellada M., Mayoral M., Graell M., Otero S., Guardia J., Castro-Fornieles J. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia. Schizophr. Res. 2013, 143(2013):125-131.
40. De Peri L., Crescini A., Deste G., Fusar-Poli P., Sacchetti E., Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr. Pharm. Des. 2012, 18(4):486-494.
41. Demjaha A., MacCabe J.H., Murray R.M. How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophr. Bull. 2012, 38(2):209-214.
42. Depp C.A., Moore D.J., Sitzer D., Palmer B.W., Eyler L.T., Roesch S., Lebowitz B.D., Jeste D.V. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. J. Affect. Disord. 2007, 101(1-3):201-209.
43. Depp C.A., Savla G.N., Vergel de Dios L.A., Mausbach B.T., Palmer B.W. Affective symptoms and intra-individual variability in the short-term course of cognitive functioning in bipolar disorder. Psychol. Med. 2013, 42(7):1409-1416.
44. Dickerson F., Boronow J.J., Stallings C., Origoni A.E., Cole S.K., Yolken R.H. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status. Psychiatry Res. 2004, 129(1):45-53.
45. Dickerson F.B., Sommerville J., Origoni A.E., Ringel N.B., Parente F. Outpatients with schizophrenia and bipolar I disorder: do they differ in their cognitive and social functioning?. Psychiatry Res. 2001, 102(1):21-27.
46. Ellison-Wright I., Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr. Res. 2010, 117(1):1-12.
47. Forcada I., Mur M., Mora E., Vieta E., Bartrés-Faz D., Portella M.J. The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder. Eur. Neuropsychopharmacol. 2015, 25(2):214-222.
48. Frangou S., Dakhil N., Landau S., Kumari V. Fronto-temporal function may distinguish bipolar disorder from schizophrenia. Bipolar Disord. 2006, 8(1):47-55.
49. Glahn D.C., Bearden C.E., Cakir S., Barrett J.A., Najt P., Serap Monkul E., Maples N., Velligan D.I., Soares J.C. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord. 2006, 8(2):117-123.
50. Goes F.S., Hamshere M.L., Seifuddin F., Pirooznia M., Belmonte-Mahon P., Breuer R., Schulze T., Nöthen M., Cichon S., Rietschel M., Holmans P., Zandi P.P., Bipolar Genome Study (BiGS), Craddock N., Potash J.B. Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl. Psychiatry 2012, 2:e180.
51. Gogos A., Joshua N., Rossell S.L. Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder. Aust. N. Z. J. Psychiatry 2010, 44(3):220-229.
52. Goodkind M., Eickhoff S.B., Oathes D.J., Ying J., Chang A., Jones-Hagata L.B., Ortega B.N., Zaiko Y.V., Roach E.L., Korgaonkar M.S., Grieve S.M., Galatzer-Levy I., Fox P.T., Etkin A. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 2015, (E-pub ahead of print).
53. Goodwin G.M., Martinez-Aran A., Glahn D.C., Vieta E. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur. Neuropsychopharmacol. 2008, 18(11):787-793.
54. Grafman J., Litvan I. Importance of deficits in executive functions. Lancet 1999, 354(1999):1921-1923.
55. Green M.F., Neuchterlein K.H., Gold J.M., Barch D.M., Cohen J., Essock S., Fenton W.S., Frese F., Goldebery T.E., Heaton R.K., Keefe R.S.E., Kern R.S., Kraemer H., Stover E., Weinberger D.R., Zalcman S., Marder S.R. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS confrerence to select cognitive domains and test criteria. Biol. Psychiatry 2004, 55(5):301-307.
56. Haahr U., Friis S., Larsen T.K., Melle I., Johannessen J.O., Opjordsmoen S., Simonsen E., Rund B.R., Vaglum P., McGlashan T. First-episode psychosis: diagnostic stability over one and two years. Psychopathology 2008, 41(5):322-329.
57. Hamilton L.S., Altshuler L.L., Townsend J., Bookheimer S.Y., Phillips O.R., Fischer J., Woods R.P., Mazziotta J.C., Toga A.W., Nuechterlein K.H., Narr K.L. Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task. Hum. Brain Mapp. 2009, 30(12):3958-3969.
58. Hamshere M.L., Stergiakouli E., Langley K., Martin J., Holmans P., Kent L., Owen M.J., Gill M., Thapar A., O'Donovan M., Craddock N. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. Br. J. Psychiatry 2013, 203(2):107-111.
59. Helldin L., Kane J.M., Karilampi U., Norlander T., Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J. Psychiatr. Res. 2006, 40(8):738-745.
60. Hill S.K., Reilly J.L., Keefe R.S.E., Gold J.M., Bishop J.R., Gershon E.S., Tamminga C.A., Pearlson G.D., Keshavan M.S., Sweenye J.A. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study. Am. J. Psychiatry 2013, 170(11):1275-1284.
61. Hofer A., Bodner T., Kaufmann A., Kemmler G., Mattarei U., Pfaffenberger N.M., Rettenbacher M.A., Trebo E., Yalcin N., Fleischhacker W.W. Symptomatic remission and neurocognitive functioning in patients with schizophrenia. Psychol. Med. 2011, 22:1-9.
62. International Schizophrenia Consortium, Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
63. Ivleva E.I., Morris D.W., Osuji J., Moates A.F., Carmody T.J., Thaker G.K., Cullum M., Tamminga C.A. Cognitive endophenotypes of psychosis within dimension and diagnosis. Psychiatry Res. 2012, 196(1):38-44.
64. Jayakar R., King T.Z., Morris R., Na S. Hippocampal volume and auditory attention on a verbal memory task with adult survivors of pediatric brain tumor. Neuropsychology 2015, 29(2):303-319.
65. Keefe R.S., Bilder R.M., Davis S.M., Harvey P.D., Palmer B.W., Gold J.M., Meltzer H.Y., Green M.F., Capuano G., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Davis C.E., Hsiao J.K., Lieberman J.A., Investigators CATIE., Neurocognitive Working Group Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch. Gen. Psychiatry 2007, 64(6):633-647.
66. Kern R.S., Green M.F., Neuchterlein K.H., Deng B.H. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr. Res. 2004, 72(1):11-19.
67. Kim D., Kim J., Koo T., Yun H., Won S. Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder. Clin. Psychopharmocol. Neurosci. 2015, 13(1):1-11.
68. Krabbendam L., Honig A., Wiersma J., Vuurman E.F., Hofman P.A., Deris M.M., Nolen W.A., Jolles J. Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr. Scand. 2000, 101(4):274-280.
69. Kraepelin E. Dementia Praecox and Paraphrenia 1919, Livingstone, Edinburgh.
70. Krishnadas R., Moore B.P., Natak A., Patel R.R. Relationship of cognitive function in patients with schizophrenia in remission to disability: a cross-sectional study in an Indian sample. Arch. Gen. Psychiatry 2007, 6:19.
71. Kurnianingsih Y.A., Kuswanto C.N., McIntyre R.S., Qiu A., Ho B.C., Sim K. Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J. Neural Transm. 2011, 118(11):1621-1639.
72. Kuswanto C.N., Sum M.Y., Sim K. Neurocognitive functioning in schizophrenia and bipolar disorder: clarifying concepts of diagnostic dichotomy vs continuum. Front. Psychiatry 2013, 4:162.
73. Larsson H., Rydén E., Boman M., Långström N., Lichtenstein P., Landén M. Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder. Br. J. Psychiatry 2013, 203(2):103-106.
74. Leavitt V.M., Goldberg T.E. Episodic memory in schizophrenia. Neuropsychol. Rev. 2009, 19(3):312-323.
75. Lee J., Altshuler L., Glahn D.C., Miklowitz D.J., Ochsner K., Green M.F. Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. Am. J. Psychiatry 2013, 170(3):334-341.
76. Lee K.W., Woon P.S., Teo Y.Y., Sim K. Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt?. Neurosci. Biobehav. Rev. 2012, 36(1):556-571.
77. Lett T.A., Voineskos A.N., Kennedy J.L., Levine B., Daskalakis Z.J. Treating working memory deficits in schizophrenia: a review of the neurobiology. Biol. Psychiatry 2014, 75(5):361-370.
78. Lewandowski K.E., Sperry S.H., Cohen B.M., Ongur D. Cognitive variability in psychotic disorders: a cross-diagnostic cluster analysis. Psychol. Med. 2014, 44(15):3239-3248.
79. Lewandowski K.E., Cohen B.M., Keshavan M.S., Öngur D. Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses. Schizophr. Res. 2011, 133(1-3):212-217.
80. Lewandowski K.E., Cohen B.M., Öngur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol. Med. 2011, 41(2):225-241.
81. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P.A., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
82. Lichenstein P., Yip B.H., Björk C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239.
83. Lindenmayer J.P., Bossie C.A., Kujawa M., Zhu Y., Canuso C.M. Dimensions of psychosis in patients with bipolar mania as measured by positive and negative syndrome scale. Psychopathology 2008, 41(4):264-270.
84. López-Jaramillo C., Lopera-Vásquez J., Gallo A., Ospina-Duque J., Bell V., Torrent C., Martínez-Arán A., Vieta E. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord. 2010, 12(5):557-567.
85. López-Jaramillo C., Lopera-Vásquez J., Ospina-Dugue J., García J., Gallo A., Cortez V., Palacio C., Torrent C., Martínez-Arán A., Vieta E. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J. Clin. Psychiatry 2010, 71(8):1055-1060.
86. Lysaker P.H., Vohs J., Hillis J.D., Kukla M., Popolo R., Salvatore G., Dimaggio G. Poor insight into schizophrenia: contributing factors, consequences and emerging treatment approaches. Expert Rev. Neurother. 2013, 13(7):785-793.
87. Mancuso S.G., Morgan V.A., Mitchell P.B., Berk M., Young A., Castle D.J. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the Second Australian national psychosis survey. J. Affect. Disord. 2014, 172C:30-37.
88. Maj M. The DSM-5 approach to psychotic disorders: is it possible to overcome the 'inherent conservative bias'?. Schizophr. Res. 2013, 150(1):38-39.
89. Martínez-Arán A., Penadés R., Vieta E., Colom F., Reinares M., Benabarre A., Salamero M., Gastó C. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother. Psychosom. 2002, 71(1):39-46.
90. Martinez-Aran A., Torrent C., Tabares-Seisdedos R., Salamero M., Daban C., Balanza-Martinez V., Sanchez-Moreno J., Manuel Goikolea J., Benabarre A., Colom F., Vieta E. Neurocognitive impairment in bipolar patients with and without history of psychosis. J. Clin. Psychiatry 2008, 69(2):233-239.
91. Martinez-Aran A., Vieta E. Cognition as a target in schizophrenia, bipolar disorder and depression. Eur. Neuropsychopharmacol. 2015, 25(2):151-157.
92. Martínez-Arán A., Vieta E., Reinares M., Colom F., Torrent C., Sánchez-Moreno J., Benabarre A., Goikolea J.M., Comes M., Salamero M. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am. J. Psychiatry 2004, 161(2):262-270.
93. Martino D.J., Samamé C., Ibañez A., Strejilevich S.A. Neurocognitive functioning in the premorbid stage and in the first episode of bipolar disorder: a systematic review. Psychiatry Res. 2015, 226(1):23-30.
94. McClellan J., Prezbindowski A., Breiger D., McCurry C. Neuropsychological functioning in early onset psychotic disorders. Schizophr. Res. 2004, 68(1):21-26.
95. McDonald C., Bullmore E.T., Sham P.C., Chitnis X., Wickham H., Bramon E., Murray R.M. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch. Gen. Psychiatry 2004, 61(10):974-984.
96. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation for schizophrenia. Am. J. Psychiatry 2007, 164(12):1791-1802.
97. McKenna B.S., Sutherland A.N., Legenkaya A.P., Eyler L.T. Abnormalities of brain response during encoding into verbal working memory among euthymic patients with bipolar disorder. Bipolar Disord. 2013, 16(3):289-299.
98. Meesters P.D., Schouws S., Stek M., de Haan L., Smit J., Eikelenboom P., Beekman A., Comijs H. Cognitive impairment in late life schizophrenia and bipolar I disorder. Int. J. Geriatr. Psychiatry 2013, 28(1):82-90.
99. Mojtabai R., Bromet E.J., Harvey P.D., Carlson G.A., Craig T.J., Fennig S. Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. Am. J. Psychiatry 2000, 157(9):1453-1460.
100. Mora E., Portella M.J., Forcada I., Vieta E., Mur M. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol. Med. 2013, 43(6):1187-1196.
101. Mur M., Portella M.J., Martinez-Aran A., Pifarre J., Vieta E. Persistent neuropsychological deficits in euthymic bipolar patients: executive function as a core deficit. J. Clin. Psychiatry 2007, 68(7):1078-1086.
102. Muralidharan K., Kozicky J.M., Bücker J., Silveira L.E., Torres I.J., Yatham L.N. Are cognitive deficits similar in remitted early bipolar I disorder patients treated with lithium or valproate? Data from the STOP-EM study. Eur. Neuropsychopharmacol. 2015, 25(2):223-230.
103. Murray R.M., Sham P., Van Os J., Zanelli J., Cannon M., McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr. Res. 2004, 71(2-3):405-416.
104. Napal O., Ojeda N., Sánchez P., Elizagárate E., Peña J., Ezcurra J., Gutiérrez M. The course of the schizophrenia and its impact on cognition: a review of literature. Actas Esp. Psiquiatr. 2012, 40(4):198-220.
105. Nuechterlein K.H., Green M.F. MATRICS Consensus Cognitive Battery 2006, MATRICS Assessment, Inc., Los Angeles.
106. Nuechterlein K.H., Ventura J., Subotnik K.L., Bartzokis G. The early longitudinal course of cognitive deficits in schizophrenia. J. Clin. Psychiatry 2014, 75(2):25-29.
107. O'Carroll R. Cognitive impairment in schizophrenia. Adv. Psychiatr. Treat. 2000, 6:161-168.
108. Ojeda N., Peña J., Sánchez P., Elizagárate E., Ezcurra J. Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia. Schizophr. Res. 2008, 101(1-3):225-233.
109. Orellana G., Slachevsky A. Executive functioning in schizophrenia. Front. Psychiatry 2013, 4:35.
110. Papadopoulos T., Parrila R.K., Kirby J.R. Cognition, Intelligence, and Achievement: A Tribute to J.P. Das 2014, Elsevier, NY, USA.
111. Pegoraro L.F.L., Dantas C.R., Banzato C.E.M., Fuentes D. Correlations between insight dimensions and cognitive functions in patients with deficits and nondeficits schizophrenia. Schizophr. Res. 2013, 147(1):91-94.
112. Pfenning A., Alda M., Young T., MacQueen G., Rybakowski J., Suwalska A., Simhandl C., Konig B., Hajek T., O'Donovan C., Wittekind D., von Quillfeldt S., Ploch J., Sauer C., Bauer M. Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplay. Int. J. Bipolar Disord. 2014, 2(16).
113. Polgár P., Réthelyi J.M., Bálint S., Komlósi S., Czobor P., Bitter I. Executive function in deficit schizophrenia: what do the dimensions of the Wisconsin Card Sorting Test tell us?. Schizophr. Res. 2010, 122(1-3):85-93.
114. Raust A., Daban C., Cochet B., Henry C., Bellivier F., Scott J. Neurocognitive performance as an endophenotype for bipolar disorder. Front. Biosci. (Elite Ed.) 2014, 6:89-103.
115. Reichenberg A., Harvey P.D., Bowie C.R., Mojtabai R., Rabinowitz J., Heaton R.K., Bromet E. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr. Bull. 2009, 35(5):1022-1029.
116. Reichenberg A., Weiser M., Rabinowitz J., Caspi A., Schmeidler J., Mark M., Kaplan Z., Davidson M. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am. J. Psychiatry 2002, 159(12):2027-2035.
117. Rosa A.R., Magalhães P.V., Czepielewski L., Sulzbach M.V., Goi P.D., Vieta E., Gama C.S., Kapczinski F. Clinical staging in bipolar disorder: focus on cognition and functioning. J. Clin. Psychiatry 2014, 75(5):450-456.
118. Rossell S.L. Category fluency performance in patients with schizophrenia and bipolar disorder: the influence of affective categories. Schizophr. Res. 2006, 82(2-3):135-138.
119. Rossi A., Arduini L., Daneluzzo E., Bustini M., Prosperini P., Stratta P. Cognitive function in euthymic bipolar patients, stabilized schizophrenic patients, and healthy controls. J. Psychiatr. Res. 2000, 34(4-5):333-339.
120. Rybakowski J.K., Permoda-Osip A., Borkowska A. Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions. Eur. Neuropsychopharmacol. 2009, 19:791-795.
121. Sanchez-Moreno J., Martinez-Aran A., Colom F., Scott J., Tabares-Seisdedos R., Sugranyes G., Torrent C., Daban C., Benabarre A., Goikolea J.M., Franco C., González-Pinto A., Ayuso-Mateos J.L., Vieta E. Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. J. Clin. Psychiatry 2009, 70(8):1120-1127.
122. Sánchez-Morla E.M., Barabash A., Martínez-Vizcaíno V., Tabarés-Seisdedos R., Balanzá-Martínez V., Gabranes-Díaz J.A., Baca-Baldomero E., Gómez J.L.S. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenia patients. Psychiatry Res. 2009, 169(3):220-228.
123. Schneider W.J., McGrew K. The Cattell-Horn-Carroll model of intelligence. Contemporary Intellectual Assessment: Theories, Tests, and Issues 2012, 99-144. Guilford, New York, USA. 3rd ed. D. Flanagan, P. Harrison (Eds.).
124. Schretlen D.J., Cascella N.G., Meyer S.M., Kingery L.R., Testa S.M., Munro C.A., Pulver A.E., Rivkin P., Rao V.A., Diaz-Asper C.M., Dickerson F.B., Yolken R.H., Pearlson G.D. Neuropsychological functioning in bipolar disorder and schizophrenia. Biol. Psychiatry 2007, 62(2):179-186.
125. Seidman L.J., Kremen W.S., Koren D., Faraone S.V., Goldstein J.M., Tsuang M.T. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr. Res. 2002, 53(1-2):31-44.
126. Shallice T. From Neuropsychology to Mental Structure 1988, Cambridge University Press, Cambridge, UK.
127. Simonsen C., Sundet K., Vaskinn A., Birkenaes A.B., Engh J.A., Hansen C.F., Jónsdóttir H., Ringen P.A., Opjordsmoen S., Friis S., Andreassen O.A. Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. Bipolar Disord. 2008, 10(2):245-255.
128. Simonsen C., Sundet K., Vaskinn A., Birkenaes A.B., Engh J.A., Færden A., Jónsdóttir H., Ringen P.A., Opjordsmoen S., Melle I., Friis S., Andreassen O.A. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr. Bull. 2011, 37(1):73-83.
129. Smith M.J., Barch D.M., Csernansky J.G. Bridging the gap between schizophrenia and psychotic mood disorders: relating neurocognitive deficits to psychopathology. Schizophr. Res. 2009, 107(1):69-75.
130. Solé B., Bonnin C.M., Torrent C., Balanzá-Martínez V., Tabarés-Seisdedos R., Popovicm D., Martínez-Arán A., Vieta E. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatr. Scand. 2012, 125(4):309-317.
131. Solé B., Martínez-Arán A., Torrent C., Bonnin C.M., Reinares M., Popovic D., Sánchez-Moreno J., Vieta E. Are bipolar II patients cognitively impaired? A systematic review. Psychol. Med. 2011, 41(9):1791-1803.
132. Sperry S.H., O'Connor L.K., Öngür D., Cohen B.M., Keshavan M.S., Lewandowski K.E. Measuring cognition in bipolar disorder with psychosis using the MATRICS Consensus Cognitive Battery. J. Int. Neuropsychol. Soc. 2015, 21(6):468-472.
133. Stone W.S., His X. Declarative memory deficits and schizophrenia: problems and prospects. Neurobiol. Learn. Mem. 2011, 96(4):544-552.
134. Stuss D.T., Benson D.F. The Frontal Lobes 1986, Raven Press, New York, USA.
135. Szoke A., Meary A., Trandafir A., Bellivier F., Roy I., Schurhoff F., Leboyer M. Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder. Eur. Psychiatry 2008, 23(1):20-25.
136. Tabarés-Seisdedos R., Balanzá-Martínez V., Sánchez-Moreno J., Martinez-Aran A., Salazar-Fraile J., Selva-Vera G., Rubio C., Mata I., Gómez-Beneyto M., Vieta E. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J. Affect. Disord. 2008, 109(3):286-299.
137. Tamminga C.A., Pearlson G., Keshavan M., Sweeney J., Clementz B., Thaker G. Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. Schizophr. Bull. 2014, 40(Suppl. 2):S131-S137.
138. Tandon R., Gaebel W., Barch D.M., Bustillo J., Gur R.E., Heckers S., Malaspina D., Owen M.J., Schultz S., Tsuang M., van Os J., Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizophr. Res. 2013, 150(1):3-10.
139. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia "Just the Facts". 4 clinical features and concept. Schizophr. Res. 2009, 110(1-3):1-23.
140. Tiihonen J., Haukka J., Henriksson M., Cannon M., Kieseppä T., Laaksonen I., Sinivuo J., Lönnqvist J. Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am. J. Psychiatry 2005, 162(10):1904-1910.
141. Torrent C., Bonnin Cdel M., Martínez-Arán A., Valle J., Amann B.L., González-Pinto A., Crespo J.M., Ibáñez Á., Garcia-Portilla M.P., Tabarés-Seisdedos R., Arango C., Colom F., Solé B., Pacchiarotti I., Rosa A.R., Ayuso-Mateos J.L., Anaya C., Fernández P., Landín-Romero R., Alonso-Lana S., Ortiz-Gil J., Segura B., Barbeito S., Vega P., Fernández M., Ugarte A., Subirà M., Cerrillo E., Custal N., Menchón J.M., Saiz-Ruiz J., Rodao J.M., Isella S., Alegría A., Al-Halabi S., Bobes J., Galván G., Saiz P.A., Balanzá-Martínez V., Selva G., Fuentes-Durá I., Correa P., Mayoral M., Chiclana G., Merchan-Naranjo J., Rapado-Castro M., Salamero M., Vieta E. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am. J. Psychiatry 2013, 170(8):852-859.
142. Torrent C., Martínez-Arán A., Daban C., Sánchez-Moreno J., Comes M., Goikolea J.M., Salamero M., Vieta E. Cognitive impairment in bipolar II disorder. Br. J. Psychiatry 2006, 189:254-259.
143. Torrent C., Martinez-Arán A., Daban C., Amann B., Balanzá-Martínez V., del Mar Bonnín C., Cruz N., Franco C., Tabarés-Seisdedos R., Vieta E. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Compr. Psychiatry 2011, 52(6):613-622.
144. van Beilen M., Pijnenborg M., van Zomeren E.H., van den Bosch E.J., Withaar F.K., Bouma A. What is measured by verbal fluency tests in schizophrenia?. Schizophr. Res. 2004, 69(2-3):267-276.
145. van Gorp W.G., Altshuler L., Theberge D.C., Wilkins J., Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch. Gen. Psychiatr. 1998, 55(1):41-46.
146. van der Werf-Eldering M.J., Burger H., Holthausen E.A.E., Aleman A., Nolen W.A. Cognitive functioning in patients with bipolar disorder: association with depressive symptoms and alcohol use. PLoS ONE 2010, 5(9):e13032.
147. Van Rheenen T.E., Rossell S.L. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder. Bipolar Disord. 2014, 16(3):318-325.
148. Varga M., Magnusson A., Flekkøy K., David A.S., Opjordsmoen S. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?. Compr. Psychiatry 2007, 48(6):583-591.
149. Verdoux H., Liraud F. Neuropsychological function in subjects with psychotic and affective disorders: relationship to diagnostic category and duration of illness. Eur. Psychiatry 2000, 15(4):236-243.
150. Vieta E. The bipolar maze: a roadmap through translational psychopathology. Acta Psychiatr. Scand. 2014, 129(5):323-327.
151. Vieta E., Phillips M.L. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr. Bull. 2007, 33:886-892.
152. Vöhringer P.A., Barroilhet S.A., Amerio A., Reale M.L., Alvear K., Vergne D., Ghaemi S.N. Cognitive impairment in bipolar disorder and schizophrenia: a systematic review. Front. Psychiatry 2013, 4:87.
153. Vreeker A., van Bergen A.H., Kahn R.S. Cognitive enhancing agents in schizophrenia and bipolar disorder. Eur. Neuropsychopharmacol. 2015, 25:969-1002.
154. Whitton A.E., Treadway M.T., Pizzagalli D.A. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr. Opin. Psychiatry 2015, 28(1):7-12.
155. Williams H.J., Norton N., Dwyer S., Moskvina V., Nikolov I., Carroll L., Georgieva L., Williams N.M., Morris D.W., Quinn E.M., Giegling I., Ikeda M., Wood J., Lencz T., Hulman C., Lichtenstein P., Thiselton D., Maher B.S., Molecular Genetics of Schizophrenia Collaboration (MGS), International Schizophrenia Consortium (ISC), SGENE-plus GROUP, Malhotra A.K., Riley B., Kendler K.S., Gill M., Sullivan P., Purcell S., Nimgaonkar V.L., Kirov G., Holmans P., Corvin A., Rujescu D., Craddock N., Owen M.J., O'Donovan M.C. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 2011, 16(4):429-441.
156. Wingo A.P., Wingo T.S., Harvey P.D., Baldessarini R.J. Effects of lithium on cognitive performance: a meta-analysis. J. Clin. Psychiatry 2009, 70(11):1588-1597.
157. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168(5):472-485.
158. Wysokiński A., Zboralski K., Orzechowska A., Galecki P., Florkowski A., Talarowska M. Normalization of the Verbal Fluency Test on the basis of results for healthy subjects, patients with schizophrenia, patients with organic lesions of the chronic nervous system and patients with type 1 and 2 diabetes. Arch. Med. Sci. 2010, 6(3):438-446.
159. Yu K., Cheung C., Leung M., Li Q., Chua S., McAlonan G. Are bipolar disorder and schizophrenia neuroanatomically distinct? An anatomical likelihood meta-analysis. Front. Hum. Neurosci. 2010, 4:189.
160. Zabala A., Rapado M., Arango C., Robles O., de la Serna E., González C., Rodríguez-Sánchez J.M., Andrés P., Mayoral M., Bombín I. Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups. Eur. Arch. Psychiatry Clin. Neurosci. 2010, 260(3):225-233.
161. Zammit S., Allebeck P., David A.S., Dalman C., Hemmingsson T., Lundberg I., Lewis G. A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch. Gen. Psychiatry 2004, 61(4):354-360.
162. Zanelli J., Reichenberg A., Morgan K., Fearon P., Kravariti P., Morgan C., Zanelli C., Demjaha A., Jones P.B., Doody G.A. Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am. J. Psychiatry 2010, 167(1):78-85.